ヘテロクロマチンの異常と二重鎖RNAの蓄積がC9orf72の多重性毒性の基礎となっている
Yong-Jie Zhang1,2, Lin Guo3, Patrick K Gonzales4
1Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
まとめ
C9orf72におけるヘクサヌクレオチド再発は前頭葉性認知症 (FTD) とALSを引き起こす. 新しいマウスモデルでは プロリン・アルギニンのタンパク質が 脳の細胞を破壊し 神経変性や認知障害を引き起こします
科学分野:
- 神経科学
- 遺伝学
- 分子生物学
背景:
- C9orf72遺伝子のヘクサヌクレオチド再発は,前頭葉性認知症 (FTD) と筋縮性横筋硬化症 (ALS) の主要な原因である.
- これらの膨張が神経変性につながる正確な分子メカニズムは ほとんど未知のままです
研究 の 目的:
- C9orf72の重複拡大の病原性メカニズムを,病気に関連したタンパク質を発現するマウスモデルを開発することによって調査する.
- FTD と ALS の神経機能不全と神経変性へのポリ (PR) タンパク質の寄与を明らかにする.
主な方法:
- 拡張されたGGGGCC (G4C2) リピートから合成されたポリ (PR) タンパク質を発現するトランスジェニックマウスモデルの開発.
- 神経病理学的特徴の脳組織の分析には,縮,神経細胞の喪失,縮,およびタンパク質の局所化が含まれます.
- ヘテロクロマチン,HP1α,ヒストンのメチル化,および核膜を含む細胞構造に対するポリ (PR) の影響の調査.
主要な成果:
- ネズミの脳におけるポリ (PR) の発現は,進行性脳縮,神経細胞喪失,および膠質症を引き起こした.
- ポリプロテインはDNAに結合し,ヘテロクロマチンに局所化し,HP1αの液相組織を乱すことが判明した.
- ヒストンメチル化,HP1α発現,核膜構造の異常が観察され,繰り返し要素発現とdsRNA蓄積と相関していた.
結論:
- ポリ (PR) タンパク質は,ヘテロクロマチンの構造と遺伝子調節を乱すことで,C9orf72に関連したFTDとALSの病原性において重要な役割を果たします.
- これらの発見は,C9orf72に関連する神経変性疾患の基礎となる分子メカニズムに関する新しい洞察を提供します.
- 開発されたマウスモデルは,FTDとALSのさらなる研究のための貴重なツールとして機能します.
さらに関連する動画
08:26Practical Use of RNA Interference: Oral Delivery of Double-stranded RNA in Liposome Carriers for Cockroaches
Published on: May 1, 2018
9.9K
13:46Separation of Single-stranded DNA, Double-stranded DNA and RNA from an Environmental Viral Community Using Hydroxyapatite Chromatography
Published on: September 29, 2011
32.4K
関連する概念動画
Fixing Double-strand Breaks
14.6K
The double-stranded structure of DNA has two major advantages. First, it serves as a safe repository of genetic information where one strand serves as the back-up in case the other strand is damaged. Second, the double-helical structure can be wrapped around proteins called histones to form nucleosomes, which can then be tightly wound to form chromosomes. This way, DNA chains up to 2 inches long can be contained within microscopic structures in a cell. A double-stranded break not only damages...
14.6K
Fixing Double-strand Breaks
4.4K
4.4K
Lagging Strand Synthesis
61.3K
During replication, the complementary strands in double-stranded DNA are synthesized at different rates. Replication first begins on the leading strand. Replication starts later, occurs more slowly, and proceeds discontinuously on the lagging strand.
There are several major differences between synthesis of the leading strand and synthesis of the lagging strand. 1) Leading strand synthesis happens in the direction of replication fork opening, whereas lagging strand synthesis happens in the...
There are several major differences between synthesis of the leading strand and synthesis of the lagging strand. 1) Leading strand synthesis happens in the direction of replication fork opening, whereas lagging strand synthesis happens in the...
61.3K
Heterochromatin
4.7K
4.7K
Heterochromatin
18.7K
The extent of chromatin compaction can be studied by staining chromatin using specific DNA binding dyes. Under the microscope, the dense-compacted regions that take up more dye are called heterochromatin. Heterochromatin is further classified into two forms – constitutive heterochromatin and facultative heterochromatin.
Constitutive heterochromatin: It is a highly compact region of chromatin that is mostly concentrated in the centromere and telomere. Unlike euchromatin, the amino acid at...
Constitutive heterochromatin: It is a highly compact region of chromatin that is mostly concentrated in the centromere and telomere. Unlike euchromatin, the amino acid at...
18.7K
RNA Interference
28.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.0K
